SCHEMBL3618059

SCHEMBL3618059

CC(C)(C)[Si](C)(C)OCCN(C#N)c1ccc(NC(=O)c2ccccc2NC(=O)c2ccc(Cl)s2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS12 P56730 3/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
KMT2A Q03164 6/20 0.40
MEN1 O00255 5/20 0.40
LMNA P02545 3/20 0.40
HTT P42858 2/20 0.40
RECQL P46063 2/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 2/20 0.38
F10 P00742 3/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 3/20 0.36
TSHR P16473 1/20 0.36
INSR P06213 1/20 0.35
ITK Q08881 1/20 0.35
STK33 Q9BYT3 1/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
RXFP1 Q9HBX9 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3608503 0.91 PRSS12 (0.43) PRSS12SMN1; SMN2KMT2AMEN1HTT
SCHEMBL3622782 0.90 PRSS12 (0.38) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3617006 0.90 PRSS12 (0.37) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3619119 0.90 PRSS12 (0.39) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3621092 0.90 PRSS12 (0.39) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3609334 0.89 PRSS12 (0.38) PRSS12SMN1; SMN2KMT2AMEN1HTT
SCHEMBL3621698 0.89 PRSS12 (0.38) PRSS12SMN1; SMN2KMT2AMEN1HTT
SCHEMBL3623718 0.89 NPC1 (0.37) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3621920 0.88 F10 (0.43) PRSS12SMN1; SMN2KMT2AMEN1LMNA
SCHEMBL3616443 0.88 KMT2A (0.36) PRSS12KMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004292-A1 Iminooxazolidine Derivatives and Their Use BAYER HEALTHCARE AG (DE) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004292-A1 Iminooxazolidine Derivatives and Their Use PPOX, XDH, PNPO PRSS12 3975/4885SMN1; SMN2 1729/4885KMT2A 4031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.